[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CMO Peptide Market, Global Outlook and Forecast 2022-2028

April 2022 | 102 pages | ID: C10E0956B452EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

This report contains market size and forecasts of CMO Peptide in Global, including the following market information:

Global CMO Peptide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CMO Peptide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

APIs and Intermediates Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CMO Peptide include Bachem, PolyPeptide, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma and ScinoPharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CMO Peptide companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CMO Peptide Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CMO Peptide Market Segment Percentages, by Type, 2021 (%)
  • APIs and Intermediates
  • FDF
Global CMO Peptide Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global CMO Peptide Market Segment Percentages, by Application, 2021 (%)
  • Commercial
  • Academic Research
  • Other
Global CMO Peptide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CMO Peptide Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CMO Peptide revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CMO Peptide revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Bachem
  • PolyPeptide
  • USV Peptides
  • Thermofischer
  • Bio Basic
  • JPT
  • Genscript
  • Xinbang Pharma
  • ScinoPharm
  • AmbioPharm
  • SN Biopharm
  • CBL
  • Piramal Pharma
  • CordenPharma
  • CPC Scientific
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 CMO Peptide Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global CMO Peptide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CMO PEPTIDE OVERALL MARKET SIZE

2.1 Global CMO Peptide Market Size: 2021 VS 2028
2.2 Global CMO Peptide Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top CMO Peptide Players in Global Market
3.2 Top Global CMO Peptide Companies Ranked by Revenue
3.3 Global CMO Peptide Revenue by Companies
3.4 Top 3 and Top 5 CMO Peptide Companies in Global Market, by Revenue in 2021
3.5 Global Companies CMO Peptide Product Type
3.6 Tier 1, Tier 2 and Tier 3 CMO Peptide Players in Global Market
  3.6.1 List of Global Tier 1 CMO Peptide Companies
  3.6.2 List of Global Tier 2 and Tier 3 CMO Peptide Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global CMO Peptide Market Size Markets, 2021 & 2028
  4.1.2 APIs and Intermediates
  4.1.3 FDF
4.2 By Type - Global CMO Peptide Revenue & Forecasts
  4.2.1 By Type - Global CMO Peptide Revenue, 2017-2022
  4.2.2 By Type - Global CMO Peptide Revenue, 2023-2028
  4.2.3 By Type - Global CMO Peptide Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global CMO Peptide Market Size, 2021 & 2028
  5.1.2 Commercial
  5.1.3 Academic Research
  5.1.4 Other
5.2 By Application - Global CMO Peptide Revenue & Forecasts
  5.2.1 By Application - Global CMO Peptide Revenue, 2017-2022
  5.2.2 By Application - Global CMO Peptide Revenue, 2023-2028
  5.2.3 By Application - Global CMO Peptide Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global CMO Peptide Market Size, 2021 & 2028
6.2 By Region - Global CMO Peptide Revenue & Forecasts
  6.2.1 By Region - Global CMO Peptide Revenue, 2017-2022
  6.2.2 By Region - Global CMO Peptide Revenue, 2023-2028
  6.2.3 By Region - Global CMO Peptide Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America CMO Peptide Revenue, 2017-2028
  6.3.2 US CMO Peptide Market Size, 2017-2028
  6.3.3 Canada CMO Peptide Market Size, 2017-2028
  6.3.4 Mexico CMO Peptide Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe CMO Peptide Revenue, 2017-2028
  6.4.2 Germany CMO Peptide Market Size, 2017-2028
  6.4.3 France CMO Peptide Market Size, 2017-2028
  6.4.4 U.K. CMO Peptide Market Size, 2017-2028
  6.4.5 Italy CMO Peptide Market Size, 2017-2028
  6.4.6 Russia CMO Peptide Market Size, 2017-2028
  6.4.7 Nordic Countries CMO Peptide Market Size, 2017-2028
  6.4.8 Benelux CMO Peptide Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia CMO Peptide Revenue, 2017-2028
  6.5.2 China CMO Peptide Market Size, 2017-2028
  6.5.3 Japan CMO Peptide Market Size, 2017-2028
  6.5.4 South Korea CMO Peptide Market Size, 2017-2028
  6.5.5 Southeast Asia CMO Peptide Market Size, 2017-2028
  6.5.6 India CMO Peptide Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America CMO Peptide Revenue, 2017-2028
  6.6.2 Brazil CMO Peptide Market Size, 2017-2028
  6.6.3 Argentina CMO Peptide Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa CMO Peptide Revenue, 2017-2028
  6.7.2 Turkey CMO Peptide Market Size, 2017-2028
  6.7.3 Israel CMO Peptide Market Size, 2017-2028
  6.7.4 Saudi Arabia CMO Peptide Market Size, 2017-2028
  6.7.5 UAE CMO Peptide Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bachem
  7.1.1 Bachem Corporate Summary
  7.1.2 Bachem Business Overview
  7.1.3 Bachem CMO Peptide Major Product Offerings
  7.1.4 Bachem CMO Peptide Revenue in Global Market (2017-2022)
  7.1.5 Bachem Key News
7.2 PolyPeptide
  7.2.1 PolyPeptide Corporate Summary
  7.2.2 PolyPeptide Business Overview
  7.2.3 PolyPeptide CMO Peptide Major Product Offerings
  7.2.4 PolyPeptide CMO Peptide Revenue in Global Market (2017-2022)
  7.2.5 PolyPeptide Key News
7.3 USV Peptides
  7.3.1 USV Peptides Corporate Summary
  7.3.2 USV Peptides Business Overview
  7.3.3 USV Peptides CMO Peptide Major Product Offerings
  7.3.4 USV Peptides CMO Peptide Revenue in Global Market (2017-2022)
  7.3.5 USV Peptides Key News
7.4 Thermofischer
  7.4.1 Thermofischer Corporate Summary
  7.4.2 Thermofischer Business Overview
  7.4.3 Thermofischer CMO Peptide Major Product Offerings
  7.4.4 Thermofischer CMO Peptide Revenue in Global Market (2017-2022)
  7.4.5 Thermofischer Key News
7.5 Bio Basic
  7.5.1 Bio Basic Corporate Summary
  7.5.2 Bio Basic Business Overview
  7.5.3 Bio Basic CMO Peptide Major Product Offerings
  7.5.4 Bio Basic CMO Peptide Revenue in Global Market (2017-2022)
  7.5.5 Bio Basic Key News
7.6 JPT
  7.6.1 JPT Corporate Summary
  7.6.2 JPT Business Overview
  7.6.3 JPT CMO Peptide Major Product Offerings
  7.6.4 JPT CMO Peptide Revenue in Global Market (2017-2022)
  7.6.5 JPT Key News
7.7 Genscript
  7.7.1 Genscript Corporate Summary
  7.7.2 Genscript Business Overview
  7.7.3 Genscript CMO Peptide Major Product Offerings
  7.7.4 Genscript CMO Peptide Revenue in Global Market (2017-2022)
  7.7.5 Genscript Key News
7.8 Xinbang Pharma
  7.8.1 Xinbang Pharma Corporate Summary
  7.8.2 Xinbang Pharma Business Overview
  7.8.3 Xinbang Pharma CMO Peptide Major Product Offerings
  7.8.4 Xinbang Pharma CMO Peptide Revenue in Global Market (2017-2022)
  7.8.5 Xinbang Pharma Key News
7.9 ScinoPharm
  7.9.1 ScinoPharm Corporate Summary
  7.9.2 ScinoPharm Business Overview
  7.9.3 ScinoPharm CMO Peptide Major Product Offerings
  7.9.4 ScinoPharm CMO Peptide Revenue in Global Market (2017-2022)
  7.9.5 ScinoPharm Key News
7.10 AmbioPharm
  7.10.1 AmbioPharm Corporate Summary
  7.10.2 AmbioPharm Business Overview
  7.10.3 AmbioPharm CMO Peptide Major Product Offerings
  7.10.4 AmbioPharm CMO Peptide Revenue in Global Market (2017-2022)
  7.10.5 AmbioPharm Key News
7.11 SN Biopharm
  7.11.1 SN Biopharm Corporate Summary
  7.11.2 SN Biopharm Business Overview
  7.11.3 SN Biopharm CMO Peptide Major Product Offerings
  7.11.4 SN Biopharm CMO Peptide Revenue in Global Market (2017-2022)
  7.11.5 SN Biopharm Key News
7.12 CBL
  7.12.1 CBL Corporate Summary
  7.12.2 CBL Business Overview
  7.12.3 CBL CMO Peptide Major Product Offerings
  7.12.4 CBL CMO Peptide Revenue in Global Market (2017-2022)
  7.12.5 CBL Key News
7.13 Piramal Pharma
  7.13.1 Piramal Pharma Corporate Summary
  7.13.2 Piramal Pharma Business Overview
  7.13.3 Piramal Pharma CMO Peptide Major Product Offerings
  7.13.4 Piramal Pharma CMO Peptide Revenue in Global Market (2017-2022)
  7.13.5 Piramal Pharma Key News
7.14 CordenPharma
  7.14.1 CordenPharma Corporate Summary
  7.14.2 CordenPharma Business Overview
  7.14.3 CordenPharma CMO Peptide Major Product Offerings
  7.14.4 CordenPharma CMO Peptide Revenue in Global Market (2017-2022)
  7.14.5 CordenPharma Key News
7.15 CPC Scientific
  7.15.1 CPC Scientific Corporate Summary
  7.15.2 CPC Scientific Business Overview
  7.15.3 CPC Scientific CMO Peptide Major Product Offerings
  7.15.4 CPC Scientific CMO Peptide Revenue in Global Market (2017-2022)
  7.15.5 CPC Scientific Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. CMO Peptide Market Opportunities & Trends in Global Market
Table 2. CMO Peptide Market Drivers in Global Market
Table 3. CMO Peptide Market Restraints in Global Market
Table 4. Key Players of CMO Peptide in Global Market
Table 5. Top CMO Peptide Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CMO Peptide Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CMO Peptide Revenue Share by Companies, 2017-2022
Table 8. Global Companies CMO Peptide Product Type
Table 9. List of Global Tier 1 CMO Peptide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CMO Peptide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CMO Peptide Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CMO Peptide Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CMO Peptide Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CMO Peptide Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CMO Peptide Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CMO Peptide Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CMO Peptide Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CMO Peptide Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CMO Peptide Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CMO Peptide Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CMO Peptide Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CMO Peptide Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CMO Peptide Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CMO Peptide Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CMO Peptide Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CMO Peptide Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CMO Peptide Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CMO Peptide Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CMO Peptide Revenue, (US$, Mn), 2023-2028
Table 30. Bachem Corporate Summary
Table 31. Bachem CMO Peptide Product Offerings
Table 32. Bachem CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 33. PolyPeptide Corporate Summary
Table 34. PolyPeptide CMO Peptide Product Offerings
Table 35. PolyPeptide CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 36. USV Peptides Corporate Summary
Table 37. USV Peptides CMO Peptide Product Offerings
Table 38. USV Peptides CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 39. Thermofischer Corporate Summary
Table 40. Thermofischer CMO Peptide Product Offerings
Table 41. Thermofischer CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 42. Bio Basic Corporate Summary
Table 43. Bio Basic CMO Peptide Product Offerings
Table 44. Bio Basic CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 45. JPT Corporate Summary
Table 46. JPT CMO Peptide Product Offerings
Table 47. JPT CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 48. Genscript Corporate Summary
Table 49. Genscript CMO Peptide Product Offerings
Table 50. Genscript CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 51. Xinbang Pharma Corporate Summary
Table 52. Xinbang Pharma CMO Peptide Product Offerings
Table 53. Xinbang Pharma CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 54. ScinoPharm Corporate Summary
Table 55. ScinoPharm CMO Peptide Product Offerings
Table 56. ScinoPharm CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 57. AmbioPharm Corporate Summary
Table 58. AmbioPharm CMO Peptide Product Offerings
Table 59. AmbioPharm CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 60. SN Biopharm Corporate Summary
Table 61. SN Biopharm CMO Peptide Product Offerings
Table 62. SN Biopharm CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 63. CBL Corporate Summary
Table 64. CBL CMO Peptide Product Offerings
Table 65. CBL CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 66. Piramal Pharma Corporate Summary
Table 67. Piramal Pharma CMO Peptide Product Offerings
Table 68. Piramal Pharma CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 69. CordenPharma Corporate Summary
Table 70. CordenPharma CMO Peptide Product Offerings
Table 71. CordenPharma CMO Peptide Revenue (US$, Mn), (2017-2022)
Table 72. CPC Scientific Corporate Summary
Table 73. CPC Scientific CMO Peptide Product Offerings
Table 74. CPC Scientific CMO Peptide Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. CMO Peptide Segment by Type in 2021
Figure 2. CMO Peptide Segment by Application in 2021
Figure 3. Global CMO Peptide Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CMO Peptide Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CMO Peptide Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CMO Peptide Revenue in 2021
Figure 8. By Type - Global CMO Peptide Revenue Market Share, 2017-2028
Figure 9. By Application - Global CMO Peptide Revenue Market Share, 2017-2028
Figure 10. By Region - Global CMO Peptide Revenue Market Share, 2017-2028
Figure 11. By Country - North America CMO Peptide Revenue Market Share, 2017-2028
Figure 12. US CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CMO Peptide Revenue Market Share, 2017-2028
Figure 16. Germany CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 17. France CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CMO Peptide Revenue Market Share, 2017-2028
Figure 24. China CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 28. India CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CMO Peptide Revenue Market Share, 2017-2028
Figure 30. Brazil CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CMO Peptide Revenue Market Share, 2017-2028
Figure 33. Turkey CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CMO Peptide Revenue, (US$, Mn), 2017-2028
Figure 37. Bachem CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. PolyPeptide CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. USV Peptides CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermofischer CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio Basic CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. JPT CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genscript CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Xinbang Pharma CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. ScinoPharm CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AmbioPharm CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. SN Biopharm CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. CBL CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Piramal Pharma CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. CordenPharma CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. CPC Scientific CMO Peptide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications